New hope for rare lung infection: weekly drug shows promise in early trial
NCT ID NCT06794554
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called rezafungin for people with a long-term lung infection caused by a fungus (chronic pulmonary aspergillosis) who have few other treatment choices. About 60 adults will receive the drug once a week for 6 months. Researchers will check if the treatment improves symptoms and lung scans, and monitor for side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PULMONARY ASPERGILLOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asklepios Lungenfachklinik Gauting
Gauting, Germany
-
Brussels University Hospital
Brussels, Belgium
-
CHU Amiens Picardie
Amiens, France
-
CHU Arnaud de Villeneuve
Montpellier, France
-
CHU Bordeaux
Pessac, France
-
CHU UCL Namur
Yvoir, Belgium
-
Chonnam National University Hospital
Gwangju, South Korea
-
Evangelische Lungenklinik Berlin
Berlin, Germany
-
Hospital La Fe
Valencia, Spain
-
Hospital Sant Joan de Deu de Martorell
Martorell, Spain
-
Hospital Universitari de Bellvitge
Barcelona, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
-
Humanitas Research Hospital
Rozzano, Italy
-
INMI Lazzaro Spallanzaniconsu
Roma, Italy
-
Imperial College Hospital
London, United Kingdom
-
Institut Coeur Poumon CHU
Lille, France
-
Kepler University Hospital
Linz, Austria
-
Leeds Teaching Hospital
Leeds, United Kingdom
-
Manchester University Hospital
Manchester, United Kingdom
-
Országos Korányi Pulmonológiai Intézet
Budapest, Hungary
-
Radboud Universitair Medisch Centrum Stichting
Nijmegen, Netherlands
-
Ramón y Cajal Hospital
Madrid, Spain
-
Royal Brompton Hospital, Guy's and St. Thomas' Hospital
London, United Kingdom
-
Royal Papworth Hospital
Cambridge, United Kingdom
-
Seoul National University Bundang Hospital
Seoul, South Korea
-
Seoul National University Hospital
Seoul, South Korea
-
Severance Hospital, Yonsei University Health System
Seoul, South Korea
-
UZ Gent
Ghent, Belgium
-
University College London (UCL) Hospitals
London, United Kingdom
-
University Hospital Leuven
Leuven, Belgium
-
University Hospitals of Derby and Burton
Derby, United Kingdom
-
University of Cologne
Cologne, Germany
-
University of Dundee
Dundee, United Kingdom
-
University of Genova, San Martino Hospital
Genova, Italy
-
University of Pisa
Pisa, Italy
-
Vall d'Hebron Barcelona Hospital Campus
Barcelona, Spain
-
Western General Hospital
Edinburgh, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.